| Literature DB >> 24223342 |
Mahdi Panah Khahi1, Shaqayeq Marashi, Mohammad Reza Khajavi, Atabak Najafi, Amirabbas Yaghooti, Farsad Imani.
Abstract
BACKGROUND: Gabapentin is an anticonvulsant that has postoperative analgesic effects but there are limited studies on its postoperative administration.Entities:
Keywords: Analgesia; Gabapentin; Pain
Year: 2012 PMID: 24223342 PMCID: PMC3821121 DOI: 10.5812/aapm.4744
Source DB: PubMed Journal: Anesth Pain Med ISSN: 2228-7523
Demographic Data
| Gabapentin | Placebo |
| |
|---|---|---|---|
| Age, y, Mean ± SD | 32.81 ± 2.33 | 32.25 ± 2.24 | 0.856 |
| Sex, male/female ratio | 24/8 | 23/9 | 0.499 |
| ASA, I/II ratio | 22/10 | 18/14 | 0.179 |
| Duration to 1st dose of MS, h, Mean ± SD | 3.03 ± 0.71 | 3.28 ± 0.59 | 0.517 |
| Required dose of MS, mg, Mean ± SD | 6.25 ± 0.62 | 5.72 ± 0.79 | 0.577 |
Abbreviations: MS, morphine sulfate; ASA, American Society of Anesthesiology.
VAS Score Between Groups Based on Time
| 2 Hour | 12 Hour | 24 Hour | |
|---|---|---|---|
| Gabapentin, Mean ± SD | 5.34 ± 0.79 | 6.97 ± 0.73 | 2.69 ± 0.54 |
| Placebo, Mean ± SD | 5.16 ± 0.98 | 7.44 ± 0.87 | 2.47 ± 0.34 |
|
| 0.76 | 0.406 | 0.457 |